Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: A Multicenter Cohort Study

• DOI: 10.1016/j.cgh.2024.09.034
• Publication Date: 2024-11-05T02:08:54Z
• Authors: Guillaume Le Cosquer; Julien Kirchgesner; Cyrielle Gilletta...; Philippe Seksik; Aurélien Amiot; David Laharie; Maria Nachury; Cléa Rouillon; Vered Abitbol; Alexandre Nuzzo; Stéphane Nancey; Mathurin Fumery; Amélie Biron; Nicolas Richard; Romain Altwegg; Driffa Moussata; Benedicte Caron; Mathias Vidon; Catherine Reenaers; Mathieu Uzzan; Jean-Marie Reimund; Mélanie Serrero; Marion Simon; Alban Benezech; Félix Goutorbe; Anne-Laure Pelletier; Ludovic Caillo; Charlotte Vaysse; Florian Poullenot; Barbara Bournet; Samira Denguir; Frank Zerbib; Pauline Rivière; Charlotte Gagnière; Julie Assaraf; Guillaume Cadiot; Hedia Brixi; Guillaume Savoye; Clara Yzet; Franck Brazier; Laurent Peyrin-Bi...; Mellie Heinemann; Nicolas Vigneron; Marie Coisnon; Justine Amaro; Mira Raad; Charlotte Mailhat
• Keywords: Inflammatory breast cancer

Breast cancer is the most common malignancy observed in patients with inflammatory bowel diseases (IBD). The aim of our study was to evaluate incident rate (recurrence or new-onset cancer) a cohort IBD history breast according subsequent treatment provided.